Kymos – Our headquarters in Barcelona
Kymos S.L. was founded in Barcelona in 2001 by a team of R&D scientists with decades of experience in pharmaceutical development from early research to final formulation and scale up trials for commercialization. The company was established at the Barcelona Science Park and rapidly expanded despite high competition. In 2011 Kymos took over Ipsen Pharma’s immunology team to create a pioneering biological division. In 2015 Kymos moved to a brand-new laboratory at the Vallès Technology Park. In 2016 Kymos acquired Italian CRO Pharmaprogress. In 2018, steady growth called for two successive extensions with a new office building and laboratories. In 2020 Kymos acquired German CRO Proytic. In 2021 the Kymos Group is made up of a two-building HQ plus two European sites, 14 laboratory departments, 170 highly trained experts and 5,000 m2 worth of facilities and top-of-the-line instruments.
KYMOS IN BARCELONA
The Kymos Group is headquartered at the Vallès Technology Park (PTV) in Cerdanyola del Vallès, about 20 minutes’ drive away from Barcelona city center and at walking distance from the Autonomous University of Barcelona (UAB), the Alba Syncrothon and multiple biopharmaceutical companies. Our HQ complex consists of two free-standing buildings measuring a total of 3,000m2: The first one (Building 5) contains our main offices and general services including Finances, Marketing and Sales, Quality Assurance, Archive, IT and Management. The second one (Building 7) is home to our 8 state-of-the-art, tailor designed laboratories:
• Bioanalysis of Small Molecules (aka Mass Spec and Permeation)
• Bioanalysis of Large Molecules (aka Immunology)
• Analytical Development and Validation
• Quality Control of Small Molecules
• Quality Control of Large Molecules (aka Biopharmaceutical testing)
• Elemental Analysis
• Microbiology
• Stabilities
